Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Chen, Hua ^a   Huang, Qiang ^a   Dong, Jun ^a   Zhai, De Zhong ^a   Wang, Ai Dong ^a   Lan, Qing ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE 1; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; CDC2 PROTEIN, HUMAN; CYCLIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CASE REPORT; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR XENOGRAFT; VIRUS PARTICLE; ADULT; ANIMAL; BRAIN TUMOR; CELL CULTURE; CELL DIVISION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; TUMOR CELL LINE;

ADULT; ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CYCLIN B; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 41449118564     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-29     Document Type: Article

References (38)

1. Du ZW Establishment of human malignant glioma cell line (SHG-44) and observation on its characteristics Chinese Journal of Oncology 1984, 6:241-3 (Chn) 6525937
2. Li XN Du ZW Huang Q Wu JQ Growth-inhibitory and Differentiation-inducing Activity of Dimethylformamide in Cultured Human Malignant Glioma Cells Neurosurgery 1997, 40:1250-9. 10.1097/00006123-199706000-00027 9179899
3. Li XN Du ZW Huang Q Wu JQ Modulation effects of hexamethylene bisacetamide on growth and differentiation of curtured human malignant glioma cells J Neurosurg 1996, 84:831-8. 8622158
4. Boer GJ Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. Network of European CNS Transplantation and Restoration (NECTAR) J Neurol 1994, 24:1-13. 10.1007/BF00920568
5. Singh SK Clarke ID Terasaki M Bonn VE Hawkins C Squire J Dirks PB Identification of a Cancer Stem Cell in Human Brain Tumors Cancer Res 2003, 63:5821-28. 14522905
6. Zhang QB Ji XY Huang Q Dong J Zhu YD Lan Q Differentiation profile of brain tumor stem cells: A comparative study with neural stem cells Cell Research 2006, 16(12):909-15. 10.1038/sj.cr.7310104 17088899
7. Yuhas JM Li AP Martinez AO Ladman AJ A simplified method for production and growth of multicellular tumor spheroids Cancer Res 1977, 37:3639-43. 908012
8. Kleihues P Cavenee WK (eds) World Health Organization Classification of Tumours-Pathology and Genetics - Tumors of the Nervous System. Lyon IARC Press, France 2000:9-52.
9. Mansy SS Agarose cell block: Innovated technique for the processing of urine cytology for electron microscopy examination Ultrastructural Pathology 2004, 28:15-21. 10.1080/01913120490275213 14967594
10. Kononen J Bubendorf L Kallioniemi A Bärlund M Schraml P Leighton S Torhorst J Mihatsch MJ Sauter G Kallioniemi OP Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 1998, 7:844-7. 10.1038/nm0798-844
11. Burkhardt M Mayordomo E Winzer KJ Fritzsche F Gansukh T Pahl S Weichert W Denkert C Guski H Dietel M Kristiansen G Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer J Clin Pathol 2006, 59:403-9. 10.1136/jcp.2005.028209 16484444
12. Sambrook J Fitsch EF Maniatis T Molecular Cloning: A Laboratory Manual Cold Spring Harbor, Cold Spring Harbor Press 1989
13. Ausubel FM Brent R Kingston RE Short Protocols in Molecular Biology Short protocols in molecular biology John Wiley & Sons, Inc., New York, N.Y. 5 2002
14. Huang Q Du ZW Xu GD Liu ZY Guo YH Chen GL Ma WX Tan QY Xu QN Li B Establishment of human glioma cell line - nude mice solid tumor model NHG-1 and its characteristics Chinese Journal of Oncology 1987, 9:269-72. (Chn). 3678017
15. Dai C Celestino JC Okada Y Louis DN Fuller GN Holland EC PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo Genes Dev 2001, 15:1913-25. 312748 11485986 10.1101/ gad.903001
16. Ding H Roncari L Shannon P Wu X Lau N Karaskova J Gutmann DH Squire JA Nagy A Guha A Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas Cancer Res 2001, 61:3826-36. 11325859
17. Holland EC Celestino J Dai C Schaefer L Sawaya RE Fuller GN Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice Nat Genet 2000, 25:55-7. 10.1038/75596 10802656
18. Jensen NA Pedersen KM Lihme F Rask L Nielsen JV Rasmussen TE Mitchelmore C Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas J Biol Chem 2003, 278:8300-08. 10.1074/jbc.M211195200 12501251
19. Uhrbom L Dai C Celestino JC Rosenblum MK Fuller GN Holland EC Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt Cancer Res 62:5551-8. 12359767
20. Watanabe T Yokoo H Yokoo M Yonekawa Y Kleihues P Ohgaki H Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas J Neuropathol Exp Neurol 2001, 60:1181-9. 11764090
21. Dai C Holland EC Astrocyte differentiation states and gliomas formation Cancer Journal 2003, 9:72-81.
22. Hulleman E Helin K Molecular mechanisms in gliomagenesis Adv Cancer Res 94:1-27. 10.1016/S0065-230X(05)94001-3 16095998
23. Draetta G Brizuela L Potashkin J Beach D Identification of p34 and p13, human homologues of the cell regulators of fission yeast encoded by cdc2+ and suc1+ Cell 1987, 50:319-25. 10.1016/0092-8674(87)90227-3 3297353
24. Nigg EA Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle Bioessays 1995, 17:471-80. 10.1002/bies.950170603 7575488
25. Arion D Meijer L Brizuela L Beach D Cdc2 is a component of the M phase-specific histone H1 kinase: Evidence for identity with MPF Cell 1988, 55:371-8. 10.1016/0092-8674(88)90060-8 2844417
26. Goodrich DW Wang NP Qian YW Lee EY Lee WH The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle Cell 1991, 67:293-302. 10.1016/0092-8674(91)90181-W 1655277
27. Lees JA Buchkovich KJ Marshak DR Anderson CW Harlow E The retinoblastoma protein is phosphorylated on multiple sites by human cdc2 EMBO 1991, 10:4279-90.
28. Park M Chae HD Yun J Jung M Kim YS Kim SH Han MH Shin DY Constitutive Activation of Cyclin B1-associated cdc2 Kinase Overrides p53-mediated G2-M Arrest Cancer Res 2000, 60:542-5. 10676633
29. Fluge O Bruland O Akslen LA Lillehaug JR Varhaug JE Gene expression in poorly differentiated papillary thyroid carcinomas Thyroid 2006, 16:161-75. 16676402
30. Hansel DE Dhara S Huang RC CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target Am J Surg Pathol 2005, 29:390-9. 10.1097/00000478-200503000-00014 15725809
31. Ito Y Takeda T Sakon M Monden M Tsujimoto M Matsuura N Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma Oncology 2000, 59:68-74. 10.1159/000012140 10895070
32. Bodey B Siegel SE Kaiser HE Expression of proline-directed protein kinase, (p34cdc2/p58cyclin A), a novel cell proliferation marker in childhood brain tumors In Vivo 2002, 16:589-94. 12494905
33. Huang Q Dong J Wang AD Shao NY Sun JY Li XN Lan Q Hu GX Establishment of malignant progression associated gene expression profiles in human brain gliomas Zhonghua Zhong Liu Za Zhi 2003, 25:437-40. (Chn) 14575564
34. Davies TG Bentley J Arris CE Boyle FT Curtin NJ Endicott JA Gibson AE Golding BT Griffin RJ Hardcastle IR Jewsbury P Johnson LN Mesguiche V Newell DR Noble ME Tucker JA Wang L Whitfield HJ Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor Nat Struct Biol 2002, 9:745-9. 10.1038/nsb842 12244298
35. Knockaert M Lenormand P Gray N Schultz P Pouysségur J Meijer L p42p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol Oncogene 2002, 21:6413-24. 10.1038/sj.onc.1205908 12226745
36. Silva J Chang K Hannon GJ Rivas FV RNA-interference-based functional genomics in mammalian cells: Reverse genetics coming of age Oncogene 2004, 23:8401-9. 10.1038/sj.onc.1208176 15517022
37. Recht L Jang T Savarese T Litofsky NS Neural stem cells and neurooncology: Quo vadis? J Cell Biochem 2003, 88:11-9. 10.1002/ jcb.10208 12461769
38. Vescovi AL Galli R Reynolds BA Brain tumour stem cells Nat Rev Cancer 2006, 6:425-36. 10.1038/nrc1889 16723989